Search research articles
Contact Us
Filters
Showing results (211-220 of 418) with videos related to
Page
of 42
Sort By:
Photomedicine and Laser Surgery
|
October 12, 2010
The use of the 308-nm excimer laser for the treatment of psoriasis
Suhail M Hadi, Hanadi Al-Quran, Ana Paula de Sá Earp, et al.
Journal of the American Academy of Dermatology
|
April 2, 2008
Psoriasis treatment patterns: results of a cross-sectional survey of dermatologists
Vaishali Patel, Elizabeth J Horn, Steve J Lobosco, et al.
Dermatology and Therapy
|
May 10, 2024
Real-World Long-Term Effectiveness of Risankizumab Among Patients with Moderate-to-Severe Psoriasis: Analysis from an International Medical Chart Review (RAPID) Study
Andreas Pinter, Ahmed M Soliman, Irina Pivneva, et al.
The Journal of Dermatological Treatment
|
August 27, 2024
Patient perspective on symptoms of Notalgia paresthetica: subpopulation results from the Neuropathic Itch Patient Survey (NIRVE)
Brian S Kim, Jennifer A Mohawk, Sherri So, et al.
The Journal of Dermatological Treatment
|
May 1, 2019
US real-world effectiveness of secukinumab for the treatment of psoriasis: 6-month analysis from the Corrona Psoriasis Registry
Bruce E Strober, Rebecca Germino, Adriana Guana, et al.
The Journal of Dermatological Treatment
|
September 1, 2016
Patient-reported impact of chronic urticaria compared with psoriasis in theUnited States
Meryl H Mendelson, Jonathan A Bernstein, Susan Gabriel, et al.
The Journal of Clinical and Aesthetic Dermatology
|
August 18, 2020
Efficacy of Fixed-combination Calcipotriene 0.005% and Betamethasone Dipropionate 0.064% Foam for Scalp Plaque Psoriasis: Additional Analysis of a Phase II, Randomized Clinical Study
Dharm S Patel, Karen A Veverka, Jes B Hansen, et al.
Dermatology and Therapy
|
December 18, 2020
Two-Year US Pharmacovigilance Report on Brodalumab
Mark Lebwohl, Craig Leonardi, Jashin J Wu, et al.
Clinical Therapeutics
|
April 2, 2017
Clinical Outcomes Associated with Switching or Discontinuation from Anti-TNF Inhibitors for Nonmedical Reasons
Douglas Wolf, Martha Skup, Hongbo Yang, et al.
International Journal of Dermatology
|
April 11, 2026
Use of Oral JAK Inhibitors and a TYK2 Inhibitor in the Treatment of Psoriasis-Eczema Overlap (PsEma): A Retrospective Study
Marley Cutrona, Sophie Guénin, Mindy Kresch-Vatch, et al.
Page
of 42
Search research articles
Search
Showing results (211-220 of 418) with videos related to
Sort By:
Page
of 42
Photomedicine and Laser Surgery
|
October 12, 2010
The use of the 308-nm excimer laser for the treatment of psoriasis
Suhail M Hadi, Hanadi Al-Quran, Ana Paula de Sá Earp, et al.
Journal of the American Academy of Dermatology
|
April 2, 2008
Psoriasis treatment patterns: results of a cross-sectional survey of dermatologists
Vaishali Patel, Elizabeth J Horn, Steve J Lobosco, et al.
Dermatology and Therapy
|
May 10, 2024
Real-World Long-Term Effectiveness of Risankizumab Among Patients with Moderate-to-Severe Psoriasis: Analysis from an International Medical Chart Review (RAPID) Study
Andreas Pinter, Ahmed M Soliman, Irina Pivneva, et al.
The Journal of Dermatological Treatment
|
August 27, 2024
Patient perspective on symptoms of Notalgia paresthetica: subpopulation results from the Neuropathic Itch Patient Survey (NIRVE)
Brian S Kim, Jennifer A Mohawk, Sherri So, et al.
The Journal of Dermatological Treatment
|
May 1, 2019
US real-world effectiveness of secukinumab for the treatment of psoriasis: 6-month analysis from the Corrona Psoriasis Registry
Bruce E Strober, Rebecca Germino, Adriana Guana, et al.
The Journal of Dermatological Treatment
|
September 1, 2016
Patient-reported impact of chronic urticaria compared with psoriasis in theUnited States
Meryl H Mendelson, Jonathan A Bernstein, Susan Gabriel, et al.
The Journal of Clinical and Aesthetic Dermatology
|
August 18, 2020
Efficacy of Fixed-combination Calcipotriene 0.005% and Betamethasone Dipropionate 0.064% Foam for Scalp Plaque Psoriasis: Additional Analysis of a Phase II, Randomized Clinical Study
Dharm S Patel, Karen A Veverka, Jes B Hansen, et al.
Dermatology and Therapy
|
December 18, 2020
Two-Year US Pharmacovigilance Report on Brodalumab
Mark Lebwohl, Craig Leonardi, Jashin J Wu, et al.
Clinical Therapeutics
|
April 2, 2017
Clinical Outcomes Associated with Switching or Discontinuation from Anti-TNF Inhibitors for Nonmedical Reasons
Douglas Wolf, Martha Skup, Hongbo Yang, et al.
International Journal of Dermatology
|
April 11, 2026
Use of Oral JAK Inhibitors and a TYK2 Inhibitor in the Treatment of Psoriasis-Eczema Overlap (PsEma): A Retrospective Study
Marley Cutrona, Sophie Guénin, Mindy Kresch-Vatch, et al.
Page
of 42